Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Enhanced recovery after surgery (ERAS) versus standard care for children undergoing thoracoscopic anatomical
Li Zexi1,2, Zheng Qipeng1,2, Cao Zhenhua1,2
1Capital Institute of Pediatrics, Beijing, China.
Insights
Enhanced recovery after surgery (ERAS) significantly improves pediatric thoracoscopic anatomical pulmonary resection outcomes. This approach reduces operative time, hospital stay, and costs while enhancing patient quality of life.
Area of Science:
- Pediatric Thoracic Surgery
- Minimally Invasive Surgery
- Enhanced Recovery After Surgery (ERAS)
Background:
- Thoracoscopic anatomical pulmonary resection is effective in adults but presents challenges in pediatric patients.
- The Enhanced Recovery After Surgery (ERAS) concept has shown success in adult surgical recovery.
- Investigating ERAS applicability in pediatric thoracoscopic anatomical pulmonary resection is crucial.
Purpose of the Study:
- To evaluate the effectiveness of the ERAS management model in pediatric thoracoscopic anatomical pulmonary resection.
- To compare perioperative outcomes between ERAS and standard care groups in pediatric patients.
Main Methods:
- A single-center before-after comparative study involving 522 pediatric patients undergoing thoracoscopic anatomical pulmonary resections.
- Patients were divided into an ERAS group (n=323) and a standard care group (n=199).
- Outcomes assessed included operative duration, chest-tube duration, length of hospital stay, hospitalization costs, and quality of life.
Main Results:
- The ERAS group demonstrated significantly shorter operative times (53.5 vs 97.9 minutes) and chest-tube durations (2.0 vs 4.4 days).
- ERAS was associated with a reduced length of hospital stay (7.6 vs 10.0 days) and lower hospitalization costs (CNY 31,455.3 vs 37,139.8).
- Quality of life scores were significantly higher in the ERAS group (100% vs 73.4% achieving higher grades).
Conclusions:
- The ERAS management model significantly improves postoperative recovery in pediatric thoracoscopic anatomical pulmonary resection.
- ERAS minimizes complications and decreases hospital stays, offering substantial clinical benefits for pediatric patients.
- Further validation in larger cohorts is recommended to confirm the wider applicability of ERAS in this population.
Abstract:
Thoracoscopic anatomical pulmonary resection has proven highly effective in adults. However, applying this technique to pediatric patients poses specific challenges due to their unique physiological and psychological traits. The application of the enhanced recovery after surgery (ERAS) concept has proven successful in adults, leading to an investigation into its potential effectiveness in pediatric thoracoscopic anatomical pulmonary resection. We conducted a single-center before-after comparative study at Beijing Children's Hospital including 522 children (ERAS n = 323; standard care n = 199) undergoing thoracoscopic anatomical pulmonary resections from August 2019 to November 2024. The ERAS group underwent perioperative management that adhered to ERAS principles. The outcomes evaluated encompassed operative duration, duration of tube placement, length of hospital stay, hospitalization expenses, and quality of life. Among 522 children (ERAS n = 323; standard care n = 199), ERAS was associated with shorter operative time (53.5 ± 26.4 vs 97.9 ± 50.9 minutes), shorter chest-tube duration (2.0 ± 0.9 vs 4.4 ± 2.5 days), reduced length of stay (7.6 ± 2.8 vs 10.0 ± 4.0 days), and lower hospitalization cost (CNY 31,455.3 ± 6677.9 vs 37,139.8 ± 11,481.7); all P < .001. Quality of life favored ERAS (Barthel Grade 0/1 [≥61 points]: 323/323 [100%] vs 146/199 [73.4%]; Grade 2 seen only in standard care: 53/199 [26.6%]; P < .001). The ERAS management model significantly associated with postoperative recovery, minimizes complications, and decreases hospital stays in pediatric thoracoscopic anatomical pulmonary resection, showcasing substantial clinical benefits. Additional verification in larger groups is necessary to establish its wider applicability.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

